Intervention
indacaterol and glycopyrronium (QVA149)
ClinicalTrials.gov intervention label
Clinical trials
2 shownQVA149 Versus Fluticasone/Salmeterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT01315249 · 2011-03-01
COMPLETEDA Study to Assess the Efficacy, Safety and Tolerability of Once-daily (q.d.) QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)NCT01202188 · 2010-09-01
COMPLETEDCommon conditions
Leading sponsors
Trial status mix
COMPLETED2
Phase mix
PHASE32
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.